Seeking Alpha

MYRX
Myrexis, Inc

5/26/2012, 5:03 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MYRX Market Currents more »
  • November 18, 2011 Biotech developer Myrexis (MYRX +1.2%) bucks a weak tape to close higher after it announces plans to reduce its workforce by 20% in its second restructuring this year, a move prompted by its September suspension of the development of then-lead drug candidate Azixa.
    Comment!
    [Healthcare, On the Move]
MYRX in Focus more »
MYRX News more »
MYRX Latest Transcript more »
Currently, there are no transcripts for MYRX.
MYRX Cramer more »
Currently, there are no Cramer articles on MYRX.
MYRX Instablog posts more »
  • Four Beaten-down Biotech Stocks that are on my BUY list
    Tue, Aug 23, 2011 • bioduediligence • Comment!
  • 79 Optionable Cancer Stocks Index (less than $5B) => Rx Investors.com
    Sat, Feb 19, 2011 • Justin M. Hall • Comment!
  • (INFI, CUTR, MYRX, AVOT.PK) Stock Report from CRWEFinance.com
    Mon, Nov 8, 2010 • Lynnai • Comment!
  • Biotech Milestones and Database Updates for July 6, 2010
    Tue, Jul 6, 2010 • Andrew Nava • Comment!
  • Biotech Events: June Medical and Investor Conferences (Jefferies List)
    Fri, Jun 4, 2010 • Andrew Nava • Comment!
Write a post on MYRX
MYRX StockTalks
MYRX vs. ETF Alternatives
Company Description
Currently, there's no company description for MYRX.
Sector: Healthcare
Industry: Drugs - Generic
Country: United States